[Therapeutic aspects in Gilles de la Tourette's disease].
D000293:Adolescent; D000978:Antiparkinson Agents / Q000627:therapeutic use; D002648:Child; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011613:Psychotherapy / Q000379:methods; D005879:Tourette Syndrome / Q000188:drug therapy / Q000628:therapy*
D000978:Antiparkinson Agents; D006220:Haloperidol
Therapeutische Aspekte der Gilles de la Tourette'schen Erkrankung